ARTICLE | Company News
Basilea, Grupo Biotoscana deal
September 19, 2016 7:00 AM UTC
Basilea granted Grupo Biotoscana exclusive rights to commercialize Cresemba isavuconazole and Zevtera ceftobiprole in 19 Latin American countries, including Argentina, Brazil, Columbia and Mexico. B...